Actively Recruiting
Study of Minimally Invasive Surgery Compared to Standard Medical Treatment for Adults with Spontaneous Deep Intracerebral Hemorrhage in Basal Ganglia
Led by Huynh Quoc Huy · Updated on 2025-11-19
300
Participants Needed
1
Research Sites
34 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying adults with spontaneous deep intracerebral hemorrhage, specifically in the basal ganglia, to compare the safety and effectiveness of minimally invasive surgery MIS with standard medical treatment. This observational, multicenter study aims to provide real-world evidence on how MIS performed within 72 hours of onset affects survival and functional recovery, addressing current gaps in data for this condition. Participants are enrolled within 72 hours after their hemorrhage begins, and treatment decisions, including whether to have MIS or standard care, are made by their clinical teams as part of usual practice. The study tracks patients who either receive MIS or standard medical treatment, without assigning interventions. Data are collected prospectively from hospital stays through to 180 days after onset. During the study, researchers gather clinical and imaging information, neurological assessments, lab results, and details of the treatments given. Outcomes such as survival, functional status using the Modified Rankin Scale, and any procedure-related complications are measured up to 180 days. The study also analyzes results based on timing of surgery and other factors to understand long-term safety and effectiveness in this patient group.
CONDITIONS
Brief Title
Minimally Invasive Surgery For Patients With Spontaneous Deep Intracerebral Hemorrhage
Research Team
H
Huy Q Huynh, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here